These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38731970)

  • 1. Competitive Inhibition of Okanin against
    Yang G; Liang Y; Li X; Li Z; Qin Y; Weng Q; Yan Y; Cheng Y; Qian Y; Sun L
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
    Chhibber-Goel J; Yogavel M; Sharma A
    Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Selective Novel Hits against
    Nyamai DW; Tastan Bishop Ö
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of an apicoplastic aminoacyl-tRNA synthetase from Plasmodium falciparum.
    Hoen R; Novoa EM; López A; Camacho N; Cubells L; Vieira P; Santos M; Marin-Garcia P; Bautista JM; Cortés A; Ribas de Pouplana L; Royo M
    Chembiochem; 2013 Mar; 14(4):499-509. PubMed ID: 23444099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of substrate polymorphism and conformational plasticity of Plasmodium tyrosyl-tRNA synthetase.
    Datt M
    Comput Biol Chem; 2021 Dec; 95():107582. PubMed ID: 34571426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction hijacking of tyrosine tRNA synthetase as a new whole-of-life-cycle antimalarial strategy.
    Xie SC; Metcalfe RD; Dunn E; Morton CJ; Huang SC; Puhalovich T; Du Y; Wittlin S; Nie S; Luth MR; Ma L; Kim MS; Pasaje CFA; Kumpornsin K; Giannangelo C; Houghton FJ; Churchyard A; Famodimu MT; Barry DC; Gillett DL; Dey S; Kosasih CC; Newman W; Niles JC; Lee MCS; Baum J; Ottilie S; Winzeler EA; Creek DJ; Williamson N; Parker MW; Brand S; Langston SP; Dick LR; Griffin MDW; Gould AE; Tilley L
    Science; 2022 Jun; 376(6597):1074-1079. PubMed ID: 35653481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Plasmodium falciparum Lysyl-tRNA synthetase via an anaplastic lymphoma kinase inhibitor.
    Zhou J; Huang Z; Zheng L; Hei Z; Wang Z; Yu B; Jiang L; Wang J; Fang P
    Nucleic Acids Res; 2020 Nov; 48(20):11566-11576. PubMed ID: 33053158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria.
    Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U
    Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.
    Novoa EM; Camacho N; Tor A; Wilkinson B; Moss S; Marín-García P; Azcárate IG; Bautista JM; Mirando AC; Francklyn CS; Varon S; Royo M; Cortés A; Ribas de Pouplana L
    Proc Natl Acad Sci U S A; 2014 Dec; 111(51):E5508-17. PubMed ID: 25489076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.
    Herman JD; Pepper LR; Cortese JF; Estiu G; Galinsky K; Zuzarte-Luis V; Derbyshire ER; Ribacke U; Lukens AK; Santos SA; Patel V; Clish CB; Sullivan WJ; Zhou H; Bopp SE; Schimmel P; Lindquist S; Clardy J; Mota MM; Keller TL; Whitman M; Wiest O; Wirth DF; Mazitschek R
    Sci Transl Med; 2015 May; 7(288):288ra77. PubMed ID: 25995223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and Structural Characterization of Selective Allosteric Inhibitors of the Plasmodium falciparum Drug Target, Prolyl-tRNA-synthetase.
    Hewitt SN; Dranow DM; Horst BG; Abendroth JA; Forte B; Hallyburton I; Jansen C; Baragaña B; Choi R; Rivas KL; Hulverson MA; Dumais M; Edwards TE; Lorimer DD; Fairlamb AH; Gray DW; Read KD; Lehane AM; Kirk K; Myler PJ; Wernimont A; Walpole C; Stacy R; Barrett LK; Gilbert IH; Van Voorhis WC
    ACS Infect Dis; 2017 Jan; 3(1):34-44. PubMed ID: 27798837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring dual inhibitory role of febrifugine analogues against Plasmodium utilizing structure-based virtual screening and molecular dynamic simulation.
    Pandey RK; Narula A; Naskar M; Srivastava S; Verma P; Malik R; Shah P; Prajapati VK
    J Biomol Struct Dyn; 2017 Mar; 35(4):791-804. PubMed ID: 26984239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening and Identification of Inhibitors Against Glutathione Synthetase, A Potential Drug Target of Plasmodium falciparum.
    Kumar YN; Jeyakodi G; Thulasibabu R; Gunasekaran K; Jambulingam P
    Comb Chem High Throughput Screen; 2015; 18(5):492-504. PubMed ID: 26220832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors.
    Chaudhary M; Singh V; Anvikar AR; Sahi S
    Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The growing pipeline of natural aminoacyl-tRNA synthetase inhibitors for malaria treatment.
    Saint-Léger A; Sinadinos C; Ribas de Pouplana L
    Bioengineered; 2016 Apr; 7(2):60-4. PubMed ID: 26963157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosyl-tRNA synthetase inhibitors: a patent review.
    Sun J; Lv PC; Zhu HL
    Expert Opin Ther Pat; 2017 May; 27(5):557-564. PubMed ID: 27977303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
    Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimerization of Arginyl-tRNA Synthetase by Free Heme Drives Its Inactivation in Plasmodium falciparum.
    Jain V; Yogavel M; Sharma A
    Structure; 2016 Sep; 24(9):1476-87. PubMed ID: 27502052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).
    Saxena S; Durgam L; Guruprasad L
    J Biomol Struct Dyn; 2019 Apr; 37(7):1783-1799. PubMed ID: 29718775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and functional analysis of the anti-malarial drug target prolyl-tRNA synthetase.
    Jain V; Kikuchi H; Oshima Y; Sharma A; Yogavel M
    J Struct Funct Genomics; 2014 Dec; 15(4):181-90. PubMed ID: 25047712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.